Akari Therapeutics PLC 8-K Filing
Ticker: AKTX · Form: 8-K · Filed: Dec 8, 2025 · CIK: 1541157
Sentiment: neutral
Filing Stats: 561 words · 2 min read · ~2 pages · Grade level 12.1 · Accepted 2025-12-08 08:00:32
Key Financial Figures
- $0.0001 — Market LLC Ordinary Shares, par value $0.0001 per share* N/A The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 45KB
- ex99-1.htm (EX-99.1) — 17KB
- ex99-1_001.jpg (GRAPHIC) — 103KB
- ex99-1_002.jpg (GRAPHIC) — 305KB
- ex99-1_003.jpg (GRAPHIC) — 127KB
- ex99-1_004.jpg (GRAPHIC) — 104KB
- ex99-1_005.jpg (GRAPHIC) — 115KB
- ex99-1_006.jpg (GRAPHIC) — 124KB
- ex99-1_007.jpg (GRAPHIC) — 128KB
- ex99-1_008.jpg (GRAPHIC) — 145KB
- ex99-1_009.jpg (GRAPHIC) — 134KB
- ex99-1_010.jpg (GRAPHIC) — 160KB
- ex99-1_011.jpg (GRAPHIC) — 112KB
- ex99-1_012.jpg (GRAPHIC) — 129KB
- ex99-1_013.jpg (GRAPHIC) — 140KB
- ex99-1_014.jpg (GRAPHIC) — 112KB
- ex99-1_015.jpg (GRAPHIC) — 130KB
- ex99-1_016.jpg (GRAPHIC) — 102KB
- ex99-1_017.jpg (GRAPHIC) — 145KB
- ex99-1_018.jpg (GRAPHIC) — 130KB
- ex99-1_019.jpg (GRAPHIC) — 118KB
- ex99-1_020.jpg (GRAPHIC) — 113KB
- ex99-1_021.jpg (GRAPHIC) — 120KB
- ex99-1_022.jpg (GRAPHIC) — 110KB
- ex99-1_023.jpg (GRAPHIC) — 155KB
- ex99-1_024.jpg (GRAPHIC) — 105KB
- ex99-1_025.jpg (GRAPHIC) — 125KB
- 0001493152-25-026533.txt ( ) — 4803KB
- aktx-20251208.xsd (EX-101.SCH) — 4KB
- aktx-20251208_def.xml (EX-101.DEF) — 26KB
- aktx-20251208_lab.xml (EX-101.LAB) — 36KB
- aktx-20251208_pre.xml (EX-101.PRE) — 25KB
- form8-k_htm.xml (XML) — 6KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Akari Therapeutics, Plc Date: December 8, 2025 By: /s/ Abizer Gaslightwala Name: Abizer Gaslightwala Title: President and Chief Executive Officer